Filters
Results: 1 to 10 of 10
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
ACMG Secondary Findings (Medically Actionable Genes, Including Cardio and Cancer) NGS Panel Fulgent Genetics United States | 177 | 59 |
|
Oxidative Phosphorylation Disorders NGS Panel Fulgent Genetics United States | 416 | 235 |
|
Renal / Urinary Cancer Comprehensive Panel Fulgent Genetics United States | 73 | 27 |
|
Paraganglioma-Pheochromocytoma Comprehensive Panel Fulgent Genetics United States | 29 | 11 |
|
Fulgent Genetics United States | 70 | 26 |
|
Full Comprehensive Cancer Panel Fulgent Genetics United States | 329 | 127 |
|
Fulgent Genetics United States | 5 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Fulgent Genetics United States | 1103 | 676 |
|
Fulgent Genetics United States | 155 | 69 |
|
Results: 1 to 10 of 10
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.